Services & Capabilities

Immunogenicity, Bioanalytical, and Cell-Based Assays

Immunogenicity, bioanalytical, and cell-based assays are important considerations in safety evaluations. BRT designs and validates approaches for testing immunogenicity and identification of biomarkers.

Models & Applications
  • Immunogenicity testing and assay development
  • Cell-based assays
  • Complement, cytokine, and biomarker analyses
Assays & Platforms
  • Immunoassay development/ validation/ implementation
  • T-cell function and proliferation
  • Vaccine efficacy
    • Anti-vaccine antibody responses
    • Hemagglutination assays
  • ADCC / ADCP / CDC and cell-based assays
  • Cell-based neutralization assays
  • PBMC isolation and evaluation
  • ELISA (absorbance, fluorescence, luminescence, electrochemiluminescence)
  • ELISpot
  • Flow cytometry
  • Multiplex technologies
  • Meso Scale Discovery (MSD)

Starting a study?